Jim Cramer says investors are making a mistake with the trillion-dollar tech giants
CNBC’s Jim Cramer said Thursday that he’s sticking with the market’s largest tech companies despite many delivering lackluster…
It’s a jam-packed afternoon of developments impacting 7 portfolio stocks
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
We’re exiting our position in an AI chipmaker to lock in big gains
We are exiting our position in Arm Holdings , selling our remaining 118 shares at roughly $303.46. Following…
The implications of Amazon’s $25B bond sale, and Microsoft’s evolving AI model strategy
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Jim Cramer Highlights General Mills’ “Blowout Quarter”
General Mills, Inc. (NYSE:GIS) was among the stocks Jim Cramer commented on as he advised investors on how…
The hunt for AI’s next winners defined the stock market’s holiday-shortened week
Wall Street kicked off the third quarter with mixed results after a blockbuster first half for stocks. The…
Meta stock pops on cloud push to sell excess AI compute power capacity
Shares of Meta popped 10% on Wednesday following news that the company is building out a new cloud…
Micron CEO: Customers driving hard bargain on price contributed to memory shortage
Micron CEO Sanjay Mehrotra said Tuesday that memory chipmakers aren’t the only ones to blame for the current…
The AI trade cooled and oil sank. A closer look at Wall Street’s volatile week
Wall Street spent the week debating who the biggest winners and losers of the artificial intelligence boom will…
Alphabet burnishes one of its best weapons in the battle for AI supremacy
Alphabet has squashed concerns that artificial intelligence will destroy its Google tech empire. One of its biggest weapons…
Meta’s flurry of AI initiatives this month hasn’t helped lift the stock. What will?
Meta Platforms unveiled a flurry of AI initiatives this month — from lower-cost smart glasses and an enterprise…
We’re trimming a stock into strength, raising our price target
We are selling 50 shares of Cardinal Health at roughly $235. Following the trade, Jim Cramer’s Charitable Trust…